Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 1/20 | 0.61 |
| ▸ | MTNR1B | P49286 | 1/20 | 0.61 |
| ▸ | HTR2A | P28223 | 2/20 | 0.49 |
| ▸ | ITK | Q08881 | 2/20 | 0.45 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.45 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.41 |
| ▸ | FLT3 | P36888 | 1/20 | 0.41 |
| ▸ | IDO1 | P14902 | 1/20 | 0.41 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.41 |
| ▸ | PGR | P06401 | 1/20 | 0.41 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7417773 | 0.83 | MTNR1A (0.60) | MTNR1AMTNR1BITKHRH4FLT3 | |
| SCHEMBL19921264 | 0.81 | MTNR1A (0.60) | MTNR1AMTNR1BITKHRH4FLT3 | |
| SCHEMBL5359029 | 0.80 | MTNR1A (0.60) | MTNR1AMTNR1BITKHRH4FLT3 | |
| SCHEMBL5350689 | 0.80 | MTNR1A (0.60) | MTNR1AMTNR1BITKHRH4FLT3 | |
| SCHEMBL11809545 | 0.79 | DAO (0.46) | MTNR1AMTNR1BHTR2ATAAR1HRH4 | |
| SCHEMBL11199718 | 0.76 | MTNR1A (0.62) | MTNR1AMTNR1BITKHRH4FLT3 | |
| SCHEMBL21586308 | 0.75 | EHMT2 (0.50) | MTNR1AMTNR1BITKHRH4FLT3 | |
| SCHEMBL6992510 | 0.74 | MTNR1A (0.50) | MTNR1AMTNR1BITKHRH4FLT3 | |
| SCHEMBL476670 | 0.73 | ITK (0.48) | MTNR1AMTNR1BITKHRH4FLT3 | |
| SCHEMBL20033880 | 0.71 | ITK (0.47) | MTNR1AMTNR1BITKHRH4FLT3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0749313-A4 | METHOD FOR TREATING 5HT 2B RECEPTOR RELATED CONDITIONS | LILLY CO ELI (US) | 2001-10-24 | — | — | EP | disclosed |
| US-5736544-A | ADMINISTERING TO TREAT MIGRAINE HEADACHES IN MAMMALS | ELI LILLY AND COMPANY (US) | 1998-04-07 | — | — | US | disclosed |
| US-5705519-A | ADMINISTERING A SUBSTITUTED INDOLE TO A MAMMAL | ELI LILLY AND COMPANY (US) | 1998-01-06 | — | — | US | disclosed |
| US-5688807-A | ANTIDEPRESSANTS, ANXIETY, UROGENITAL DISORDERS, HYPOTENSIVES, CARDIOVASCULAR DISORDERS | ELI LILLY AND COMPANY (US) | 1997-11-18 | — | — | US | disclosed |
| EP-0751770-A4 | 8-SUBSTITUTED TETRAHYDRO-BETA-CARBOLINES | LILLY CO ELI (US) | 1997-06-11 | — | — | EP | disclosed |
| US-5631265-A | CHEMICAL INTERMEDIATES WITH CENTRAL NERVOUS SYSTEM ACTIVITY | ELI LILLY AND COMPANY (US) | 1997-05-20 | — | — | US | disclosed |
| EP-0751770-A1 | 8-SUBSTITUTED TETRAHYDRO-BETA-CARBOLINES | ELI LILLY AND COMPANY (US) | 1997-01-08 | — | — | EP | disclosed |
| EP-0749313-A1 | METHOD FOR TREATING 5HT 2B RECEPTOR RELATED CONDITIONS | ELI LILLY AND COMPANY (US) | 1996-12-27 | — | — | EP | disclosed |
| WO-1995024200-A1 | METHOD FOR TREATING 5HT2B RECEPTOR RELATED CONDITIONS | ELI LILLY AND COMPANY (US) | 1995-09-14 | — | — | WO | disclosed |
| WO-1995024191-A1 | 8-SUBSTITUTED TETRAHYDRO-BETA-CARBOLINES | ELI LILLY AND COMPANY (US) | 1995-09-14 | — | — | WO | disclosed |